Culture cell media comes across as growth media designed for supporting cell growth. The composition of cell culture media comprises vitamins, amino acids, glucose, inorganic salts, serum, and likewise. At times, supplementary reagents/sera like growth factors, trace elements, lipids, hormones, and minerals are essential for growth of cell cultures, so as to sustain in incubation environment. By type of product, culture cell media market spans stem cell media (neutral stem cells, embryonic stem cells, mesenchymal stem cells, bone marrow), classical media, sera, and reagents. Application-wise, it’s cytogenetic, gene therapy, tissue culture and manufacturing, and biopharmaceuticals.
These days, new-fangled as well as advanced treatment of chronic ailments like cancer is linked with precision medicines. As every individual has different genetic mutations, clinicians need to customize the medicines. These precision medicines are bound to check the tumors on the basis of genetic mutations. Also, in something like breast cancer, the medical practitioners are eying genome analysis, which lets them look into specific treatments for patients. As such, the physicians are BRCA gene mutation’s DNA testing report, which would give them a fair idea of family history regarding breast or ovarian cancer. The other application areas include cardiovascular disease, oncology/cancer, infectious diseases, central nervous system, and likewise.
Neurostimulation devices are witnessing a substantial demand with increase in incidences of epilepsy, depression, chronic pain, and Parkinson’s disease. This electrical stimulation does help in treating neurological disorders by passing on the signals to the patients’ spinal cord, peripheral nervous system, and brain. Product-wise, neurostimulation devices market spans deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, gastric electric stimulators, and vagus nerve stimulators. Application-wise, it’s epilepsy, pain management, fecal and urinary incontinence, essential tremor, depression, dystonia, gastroparesis, and Parkinson’s disease.
Gene expression analysis is amongst the major revenue generators with increasing applications like drug discovery backed by development procedures, biotechnology, clinical diagnostics, and others. With CAGE (Cap Analysis of Gene Exp.) in place, promoters could be mapped comprehensively and human transcription could be started with. The other advantage is that mRNA quantification in the cells could also be started with. Process-wise, gene expression analysis market spans sample collection, cDNA synthesis & conversion, purification, PCR analysis, and data analysis & interpretation. By technique, it’s RNA exp. (DNA microarrays, northern blotting, RNA-Seq, and PCR techniques), promoter analysis (in-vitro transcription/nuclear run-on assays, gel shift assays, Chromatin Immunoprecipitation (ChiP) assays, and protein exp. & post translational modification analysis (immunoassays, 2-D gel electrophoresis, western blotting, mass spectrometry, and immunoassays).
Bioinformatics market, application-wise, says chemoinformatics, genomics, transciptomics, metabolomics, molecular phylogenetics, drug design, and likewise). Coming to technology and services, it’s sequence analysis, data warehousing, and sequence manipulation). Sector-wise, it’s agriculture bioinformatics, animal bioinformatics, and medical bioinformatics. Bioinformatics needs knowledge regarding computer science, mathematics, biology, laws of physics, chemistry.
As far as bioinformatics services are concerned, by type, it’s sequencing services (whole genome sequencing and De Novo Assembly, Exome analysis, transcriptome analysis, metagenomic analysis, ChIP-Seq analysis, and other sequencing analysis), data analysis (data mining, genomic analysis, proteomic analysis, and variant annotation and discovery), drug discovery services, differential gene expression analysis, database and management services, and others.
Ophthalmic imaging equipment are another field to ponder about. By product, they are vision care products (spectacle and contact lenses (soft contact lenses, RGP (Rigid Gas Permeable Lenses), and hybrid contact lenses)), ophthalmology surgical devices (cataract surgical devices (intraocular lenses, ophthalmic viscoelastic devices, phacoemulsification devices, cataract surgical lasers, and IoL injectors), vitreoretinal surgical devices (vitreorretinal packs, vitreoctomy machines, photocoagulation lasers, illumination devices, and virectomy probes), refractive surgical devices (femtosecond lasers, excimer lasers, and others), glaucoma surgical devices (glaucoma drainage devices, microinvasive glaucoma surgical devices, and glaucoma laser systems), ophthalmic microscopes, ophthalmic surgical accessories (surgical instruments and kits, ophthalmic forceps, ophthalmic spatulas, ophthalmic tips and handles, ophthalmic scissors, macular lenses, ophthalmic cannulas and others), diagnostic and monitoring devices (optical coherence tomography scanners, fundus cameras, perimeters/visual field analyzers, autorefractors and keratometers, and ophthalmic ultrasound imaging systems), tonometers, slit lamps, phoropters, wavefront aberrometers, optical biometry systems, ophthalmoscopes, lensmeters, corneal topography systems, chart projectors, specular microscopes, and retinoscopes).
Biosensors are being increasingly used in medicine and clinical care. The specific areas of application include patient health monitoring, diagnosis, and human health management. Coming to developments, Roche Diagnostics, partnering with SD Biosensors Inc., in July 2020, did launch SARS-CoV-2 rapid antibody test. Point-of-care setting asks for this test. In the latest scenario, BX100 from Philips helps in managing suspected and confirmed Covid-19 cases.
Osteoporosis is another condition having unavoidable impact all through. Herein, the patients are likely to break bones, forearms, hip, wrist, and spine. Geriatric population, postmenopausal women, and men aged 60 and above are usually subject to osteoporosis. Coming to osteoporosis drugs, GEDEON Richter, in August 2019, launched terrosa after patent expiry of biosimilar teriparadite.
The ailments and their courses of treatment mentioned couldn’t be on floor without clinical trial management system. By type of system, it’s licensed enterprise-based and site-based.
Persistence Market Research (PMR) has profiled the players pertaining to the snapshots of various arms of healthcare vertical as follows:
- Amgen Inc.
- AbbVie Inc.
- Bio-Optronics Inc.
- MedNet Solutions Inc.
- Gwent Group
- Pinnacle Technologies
- Johnson & Johnson Vision Care
- Eurofins Scientific
- Dassault Systemes
- Bio-Rad Laboratories
- Agilent Technologies
- Boston Scientific Corporation
- Almac Group, Inc.
- ASURAGEN, Inc.
- The Sartorius Group